24 May 2013
Keywords: repligen, claims, patent, suit, b-ms, orencia, drugmaker
Article | 16 January 2006
US drugmaker Repligen and the University of Michigan have jointly filed a complaint against drug major Bristol-Myers Squibb in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.